Jiangxi Sanxin Medtec Co Ltd - Asset Resilience Ratio
Jiangxi Sanxin Medtec Co Ltd (300453) has an Asset Resilience Ratio of 13.70% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Jiangxi Sanxin Medtec Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2025)
This chart shows how Jiangxi Sanxin Medtec Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Jiangxi Sanxin Medtec Co Ltd balance sheet assets.
Liquid Assets Composition Over Time
This chart breaks down Jiangxi Sanxin Medtec Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Jiangxi Sanxin Medtec Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥334.84 Million | 13.7% |
| Total Liquid Assets | CN¥334.84 Million | 13.70% |
Asset Resilience Insights
- Moderate Liquidity: Jiangxi Sanxin Medtec Co Ltd has 13.70% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Jiangxi Sanxin Medtec Co Ltd Industry Peers by Asset Resilience Ratio
Compare Jiangxi Sanxin Medtec Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Eyebright Medical Technology Beijing Co Ltd
SHG:688050 |
Medical Instruments & Supplies | 1.51% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
Vizionfocus Inc.
TW:4771 |
Medical Instruments & Supplies | 3.24% |
|
Pro-Dex Inc
NASDAQ:PDEX |
Medical Instruments & Supplies | 1.39% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
Mark Dynamics Indonesia Tbk PT
JK:MARK |
Medical Instruments & Supplies | 6.64% |
|
Interojo Inc
KQ:119610 |
Medical Instruments & Supplies | 6.55% |
Annual Asset Resilience Ratio for Jiangxi Sanxin Medtec Co Ltd (2015–2025)
The table below shows the annual Asset Resilience Ratio data for Jiangxi Sanxin Medtec Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.48% | CN¥157.45 Million ≈ $23.04 Million |
CN¥2.43 Billion ≈ $355.42 Million |
-1.55pp |
| 2024-12-31 | 8.03% | CN¥178.48 Million ≈ $26.12 Million |
CN¥2.22 Billion ≈ $325.25 Million |
+1.06pp |
| 2023-12-31 | 6.97% | CN¥141.57 Million ≈ $20.72 Million |
CN¥2.03 Billion ≈ $297.17 Million |
+4.69pp |
| 2022-12-31 | 2.28% | CN¥40.67 Million ≈ $5.95 Million |
CN¥1.79 Billion ≈ $261.43 Million |
+2.79pp |
| 2021-12-31 | -0.52% | CN¥-7.25 Million ≈ $-1.06 Million |
CN¥1.41 Billion ≈ $205.75 Million |
-9.28pp |
| 2020-12-31 | 8.76% | CN¥109.09 Million ≈ $15.96 Million |
CN¥1.24 Billion ≈ $182.15 Million |
+7.02pp |
| 2019-12-31 | 1.75% | CN¥20.00 Million ≈ $2.93 Million |
CN¥1.15 Billion ≈ $167.65 Million |
+2.53pp |
| 2018-12-31 | -0.78% | CN¥-6.46 Million ≈ $-944.88K |
CN¥827.43 Million ≈ $121.08 Million |
-9.58pp |
| 2016-12-31 | 8.80% | CN¥55.00 Million ≈ $8.05 Million |
CN¥625.26 Million ≈ $91.50 Million |
+7.35pp |
| 2015-12-31 | 1.44% | CN¥8.54 Million ≈ $1.25 Million |
CN¥592.28 Million ≈ $86.67 Million |
-- |
About Jiangxi Sanxin Medtec Co Ltd
Jiangxi Sanxin Medtec Co.,Ltd. engages in the research and development, manufacture, sale, and service of medical devices. It offers infusion and cardiothoracic surgery products and blood purification products, such as central concentrate delivery systems, disposable biological protein glue dispensers, disposable blood dialyzers, hemodialysis filters, hemodialysis concentrates and powders, contin… Read more